Skip to Main Content

Paper Details

EMPOWER CERVICAL-1: Effects of cemiplimab versus chemotherapy on patient-reported quality of life, functioning and symptoms among women with recurrent cervical cancer.
Eur J Cancer
8
2022
Author NameAffiliation
Yong-Man KimAsan Medical Center, University of Ulsan
  • 1 - 1

Datasets

Release 1.2